The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Immunovant Inc’s stock clocked out at $26.0, down -4.94% from its previous closing price of $27.35. In other words, the price has decreased by -$4.94 from its previous closing price. On the day, 1.85 million shares were traded. IMVT stock price reached its highest trading level at $27.34 during the session, while it also had its lowest trading level at $25.575.
Ratios:
To gain a deeper understanding of IMVT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.07 and its Current Ratio is at 9.07. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 14, 2025, Truist started tracking the stock assigning a Hold rating and target price of $16.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 07 ’26 when Stout Jay S sold 1,203 shares for $26.53 per share. The transaction valued at 31,914 led to the insider holds 199,611 shares of the business.
Van Tuyl Christopher sold 10,813 shares of IMVT for $290,943 on Dec 18 ’25. The Chief Legal Officer now owns 149,930 shares after completing the transaction at $26.91 per share. On Dec 12 ’25, another insider, Roivant Sciences Ltd., who serves as the Director of the company, bought 16,666,666 shares for $21.00 each. As a result, the insider paid 349,999,986 and bolstered with 113,317,007 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 5238389760 and an Enterprise Value of 4035319552.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.54, which has changed by 0.14626992 over the last 52 weeks, in comparison to a change of 0.15507638 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $27.80, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is 5.35%, while the 200-Day Moving Average is calculated to be 42.00%.
Shares Statistics:
It appears that IMVT traded 1.80M shares on average per day over the past three months and 1681070 shares per day over the past ten days. A total of 174.53M shares are outstanding, with a floating share count of 66.04M. Insiders hold about 58.48% of the company’s shares, while institutions hold 47.70% stake in the company. Shares short for IMVT as of 1767139200 were 16135139 with a Short Ratio of 8.97, compared to 1764288000 on 15067824. Therefore, it implies a Short% of Shares Outstanding of 16135139 and a Short% of Float of 18.56.
Earnings Estimates
. The current rating of Immunovant Inc (IMVT) is the result of assessments by 9.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.7, with high estimates of -$0.57 and low estimates of -$0.79.
Analysts are recommending an EPS of between -$2.33 and -$3.34 for the fiscal current year, implying an average EPS of -$2.93. EPS for the following year is -$3.0, with 11.0 analysts recommending between -$1.96 and -$3.98.
